Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Glyco-TRAPP: A real-time glycocalyx permeability assay for assessing transmembrane mucin barrier function in live and fixed tissues.

Created on 04 Jul 2026

Authors

Fleur Claire van de Koolwijk, Thaher Pelaseyed

Published in

Methods in enzymology. Volume 732. Pages 529-540. Epub Apr 11, 2026.

Abstract

A glycocalyx permeability assay for in situ assessment of transmembrane mucin barrier function ABSTRACT: The small intestine lacks a dense, attached mucus layer and instead relies on an apical cell surface glycocalyx as an alternative barrier mechanism to regulate host-microbiota interactions. However, quantitatively assessing the integrity of the glycocalyx barrier in a physiologically relevant setting has remained challenging. Here, we introduce the Glyco-TRAPP assay, a live imaging-based approach that enables direct, quantitative measurement of glycocalyx permeability and bacteria-epithelium interactions in intact intestinal tissue. By enabling direct functional assessment of barrier integrity in both human biopsies and experimental models, Glyco-TRAPP provides a powerful tool to uncover how molecular defects at the cell surface, compromising for example transmembrane mucin expression, localization, and glycosylation, impact glycocalyx barrier function. Glyco-TRAPP provides a functional readout that complements conventional structural or molecular analyses.

PMID:
42399060
Bibliographic data and abstract were imported from PubMed on 04 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement